Inositol nicotinate.

Each molecule of inositol nicotinate carries six nicotinic acid units esterified to a myo-inositol core, so taking both means counting the same vitamin twice. Anyone stacking a flush-free product on top of plain nicotinic acid can reach a far higher total nicotinic acid intake than either label suggests. The two are not complementary. Read them as one input arriving by two routes.

Full hydrolysis of inositol hexanicotinate releases one myo-inositol alongside the nicotinic acid. On a molar basis the inositol contribution is modest next to the gram doses used in dedicated inositol products. Anyone taking both should be aware the overlap exists, though it is small enough that it rarely changes a plan.

Nicotinic acid enters the NAD pool through the Preiss-Handler route while nicotinamide enters through the salvage route, and both end at the same place. What differs is everything upstream of that. Nicotinamide does not activate GPR109A, so it neither flushes nor produces the lipid effects that free nicotinic acid does. Substituting one for the other changes the outcome even though the vitamin activity is the same.

Nicotinamide riboside enters NAD synthesis through nicotinamide riboside kinase, a third entry point into the same pool that nicotinic acid feeds. Combining forms raises total precursor supply but does not multiply the result, because NAD synthesis is regulated and precursors are not interchangeable in their side effects. There is no evidence that stacking the two does more than either at an adequate dose.

The body makes its own niacin from tryptophan, and kynureninase, the committed step in that route, is a pyridoxal phosphate enzyme. Low vitamin B6 status throttles endogenous niacin production and raises reliance on dietary intake. This is textbook one-carbon and amino acid biochemistry, not a supplement interaction, and it is why B6 status matters when assessing niacin adequacy.

Kynurenine 3-monooxygenase, another step on the tryptophan to niacin route, is a flavin-dependent enzyme requiring FAD derived from riboflavin. Riboflavin depletion therefore reduces how much niacin a person makes from protein. The relationship runs through cofactor supply and applies whatever niacin form is taken.

Tryptophan converts to niacin equivalents at roughly a sixty to one weight ratio in people with adequate B2 and B6 status, which is why niacin requirements are stated in niacin equivalents rather than niacin alone. A protein-adequate diet supplies a meaningful share of niacin need this way. It means supplemental niacin sits on top of an endogenous supply that varies with protein intake.

Free nicotinic acid at gram doses lowers triglycerides and raises HDL, while monacolin K inhibits HMG-CoA reductase like a statin. Stacking them is an additive lipid intervention that also stacks their liver and muscle monitoring requirements. This combination belongs under clinical supervision with liver enzymes checked, not in self-directed stacking.